Article Text

Download PDFPDF
Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation
  1. Shotaro Nakamura1,2,
  2. Hongtao Ye1,
  3. Chris M Bacon1,
  4. Alison Goatly1,
  5. Hongxiang Liu1,
  6. Alison H Banham3,
  7. Roland Ventura3,
  8. Takayuki Matsumoto2,
  9. Mitsuo Iida2,
  10. Yutaka Ohji3,
  11. Takashi Yao3,
  12. Masazumi Tsuneyoshi3,
  13. Ming-Qing Du1
  1. 1Division of Molecular Histopathology, Department of Pathology, University of Cambridge, UK
  2. 2Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  3. 3Nuffield Department of Clinical Laboratory Sciences, University of Oxford, UK
  4. 4Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  1. Correspondence to:
    Shotaro Nakamura
    Division of Molecular Histopathology, Department of Pathology, University of Cambridge, Box 231, Level 3 Lab Block, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, UK; sn330{at}


Background and aims: There is a need for genetic biomarkers to guide prognosis and management of gastric mucosa-associated lymphoid tissue (MALT) lymphomas. We assessed the incidence and clinical significance of the MALT lymphoma-associated genetic abnormalities t(11;18)/API2-MALT1, t(1;14)/BCL10-IGH, t(14;18)/IGH-MALT1, t(3;14)/FOXP1-IGH, and extra copies of MALT1 and FOXP1 in gastric MALT lymphomas from Japan.

Methods: The presence of translocations and copy number changes involving MALT1, IGH and FOXP1 were assessed in 90 cases of gastric MALT lymphoma using interphase fluorescence in situ hybridisation (FISH). In cases carrying a MALT1 translocation, FISH for API2-MALT1 was performed, whereas in those carrying an IGH translocation, FISH was performed for BCL10, BCL6, BCL2, c-MYC and/or CCND1.

Results: t(11;18)/API2-MALT1 was detected in 18 of 87 (21%) cases and was significantly associated with Helicobacter pylori-negativity, resistance to H pylori eradication and Bcl10 nuclear expression. Four of 68 (6%) cases carried a translocation involving IGH and FOXP1 (n = 1), BCL2 (n = 1) or an unknown partner (n = 2). Neither t(1;14)/BCL10-IGH nor t(14;18)/IGH-MALT1 was detected. Extra copies of MALT1 and FOXP1 were detected in 18 of 71 (25%) cases and 10 of 59 (17%) cases, respectively. The presence of extra copies of MALT1 was significantly associated with progression or relapse of lymphoma, and was an independent adverse prognostic factor for event-free survival as determined by multivariate analysis.

Conclusions: t(11;18)/API2-MALT1 is frequent, whereas IGH-involved translocations are rare in gastric MALT lymphoma in Japan. The presence of extra copies of MALT1, often suggestive of partial or complete trisomy 18, is a frequent genetic aberration in gastric MALT lymphoma, which appears to predict adverse clinical behaviour.

  • CR, complete remission
  • DLBCL, diffuse large B-cell lymphoma
  • EFS, event-free survival
  • FISH, fluorescence in situ hybridisation
  • FOXP1, forkhead box protein P1
  • MALT, mucosa-associated lymphoid tissue
  • NF-κB, nuclear factor kappa B
  • OS, overall survival
  • RT-PCR, reverse-transcription polymerase chain reaction

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Published Online First 24 May 2007

  • Competing interests: None.